IP Library Assignment 065712/0988
Patent Assignment
Reel/Frame 065712/0988

Release of Security Interest

Recorded: 2023-11-30 Pages: 6
Assignor
Assignees
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.)
675 MCDONNELL BOULEVARD, HAZELWOOD, MISSOURI, 63042
MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN, DUBLIN 15, IRELAND
STRATATECH CORPORATION
510 CHARMANY DR # 169, MADISON, WISCONSIN, 53719
Covered Properties (13)
Clinical Decision Support System and Methods
Application: 16/677,435 →
Publication: US 2020/0139061
Systems and Methods for Indicating Lifetime of an NO2-to-No Reactor Cartridge Used to Deliver No for Inhalation Therapy to a Patient
Application: 16/696,142 →
Publication: US 2020/0094010
Enhanced Performance Verification Port for Therapeutic Gas Delivery
Application: 16/704,530 →
Publication: US 2020/0108214
Apparatus and Method for Detecting Liquid Level in a Clear or Partially Clear Container
Application: 16/724,786 →
Publication: US 2020/0121883
Treatment of Diseases Associated with Hepatic Stellate Cell Activation Using Ammonia-Lowering Therapies
Application: 16/732,861 →
Publication: US 2020/0206175
Systems and Methods for Delivery of Therapeutic Gas
Application: 16/748,319 →
Publication: US 2020/0155777
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Application: 16/778,696 →
Publication: US 2020/0239406
(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
Application: 16/779,796 →
Publication: US 2020/0172488
System And Method Of Administering A Pharmaceutical Gas To A Patient
Application: 16/779,912 →
Publication: US 2020/0163989
Cannula For Minimizing Dilution Of Dosing During Nitric Oxide Delivery
Application: 16/785,978 →
Publication: US 2020/0171259
Methods Of Administering High Concentrations Of Nitric Oxide
Application: 16/785,983 →
Publication: US 2020/0171264
Methods for Treating Progressive Hyperbilirubinemia
Application: 62/948,513 →
Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application: 62/965,330 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Grant of Security Interest in Intellectual Property Dec 9, 2019
From: MALLINCKRODT LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 051231/0961 →
Security Interest Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Notice of Grant of Security Interest in Intellectual Property Apr 21, 2020
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 052456/0158 →
Security Interest Apr 22, 2020
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; OCERA THERAPEUTICS, INC.; ST SHARED SERVICES LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 052463/0396 →
Assignment of Assignor's Interest Oct 7, 2020
From: VILCHEZ, REGIS
To: OCERA THERAPEUTICS, INC.
Reel/Frame 054002/0540 →
Assignment of Assignor's Interest Oct 7, 2020
From: TSENG, JACK; MAK, CARMEN; POOLA, NAGARAJU
To: OCERA THERAPEUTICS, INC.
Reel/Frame 054002/0516 →
Assignment of Assignor's Interest Oct 12, 2020
From: REARS, XIAOFENG WANG
To: MALLINCKRODT ENTERPRISES LLC
Reel/Frame 054030/0740 →
Assignment of Assignor's Interest May 19, 2021
From: JALAN, RAJIV; MOOKERJEE, RAJESHWAR PROSAD; ROMBOUTS, KRISTA; ANDREOLA, FAUSTO
To: UCL BUSINESS PLC
Reel/Frame 056285/0656 →
Change of Name May 19, 2021
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD
Reel/Frame 056399/0962 →
Assignment of Assignor's Interest Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 056433/0640 →
Change of Name Jun 3, 2021
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 056476/0162 →
Assignment of Assignor's Interest Sep 27, 2021
From: ANDERSON, KEITH; BEHLING, JIM
To: OCERA THERAPEUTICS, INC.
Reel/Frame 057613/0433 →
Assignment of Assignor's Interest Sep 27, 2021
From: WATT, STEPHEN WILLIAM; DOUGAN, CHRISTINE HENDERSON
To: SOLID FORM SOLUTIONS LTD.
Reel/Frame 057614/0431 →
Assignment of Assignor's Interest Sep 27, 2021
From: HELSINN ADVANCED SYNTHESIS SA
To: OCERA THERAPEUTICS, INC.
Reel/Frame 057620/0183 →
Assignment of Assignor's Interest Sep 27, 2021
From: SOLID FORM SOLUTIONS LTD.
To: OCERA THERAPEUTICS, INC.
Reel/Frame 057613/0006 →
Assignment of Assignor's Interest Sep 27, 2021
From: MANINI, PETER; FIGINI, ATTILIA
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 057614/0343 →
Security Interest Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Release of Security Interest Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Notice of Grant of Security Interest in Intellectual Property Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913 Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 052456, Frame 0158 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0133 →
Release of Patent Security Interests Recorded at Reel 051231, Frame 0961 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065609/0811 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536 Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Assignment of Assignor's Interest Jan 31, 2024
From: OCERA THERAPEUTICS, INC.
To: OCERA THERAPEUTICS LLC
Reel/Frame 066403/0804 →